BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5166 related articles for article (PubMed ID: 3384660)

  • 41. Adjuvant chemotherapy of malignant melanoma. A pilot study.
    Hansson J; Ringborg U; Lagerlöf B; Strander H
    Am J Clin Oncol; 1985 Feb; 8(1):47-50. PubMed ID: 3993625
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Chemotherapy of malignant melanoma using DTIC].
    Zaumseil RP; Fiedler H; Lübbe D
    Dermatol Monatsschr; 1977 Nov; 163(11):905-14. PubMed ID: 590586
    [No Abstract]   [Full Text] [Related]  

  • 43. [T-lymphocytes in the peripheral blood. Study on 113 patients with malignant melanoma].
    Klein R; Krüger GR; Sesterhenn K
    Z Hautkr; 1978 Feb; 53(3):62-6. PubMed ID: 305173
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The malignant melanoma: criteria for the prognosis and therapy].
    Nagel GA; Rufli T
    Schweiz Med Wochenschr; 1978 Sep; 108(35):1355-9. PubMed ID: 684397
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complete remission of metastatic malignant melanoma after surgery in association with development of systemic vitiligo.
    Nishitani N; Bito T; Ikeda T; Tokura Y; Nishigori C
    J Dermatol; 2010 Aug; 37(8):770-2. PubMed ID: 20649729
    [No Abstract]   [Full Text] [Related]  

  • 46. [Dacarbazin -- therapy of metastazising malignant melanoma (author's transl)].
    Zaumseil RP
    Zentralbl Chir; 1979; 104(15):975-81. PubMed ID: 92112
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Postoperative DAV-IFN-β therapy does not improve survival rates of stage II and stage III melanoma patients significantly.
    Matsumoto T; Yokota K; Sawada M; Sakakibara A; Shibata S; Yasue S; Tomita Y; Yatsuya H; Akiyama M
    J Eur Acad Dermatol Venereol; 2013 Dec; 27(12):1514-20. PubMed ID: 23198869
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Successful therapy of secondary melanoma of the orbit with DTIC].
    Ballin R; Lommatzsch PK; Klöppel R
    Klin Monbl Augenheilkd; 1987 Jul; 191(1):50-2. PubMed ID: 2443753
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjuvant and neoadjuvant chemotherapy with dacarbazine in high-risk childhood melanoma.
    Boddie AW; Cangir A
    Cancer; 1987 Oct; 60(8):1720-3. PubMed ID: 3651999
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Results of a prospective randomized trial using DTIC and interferon as adjuvant therapy for stage I malignant melanoma.
    Kerin MJ; Gillen P; Monson JR; Wilkie J; Keane FB; Tanner WA
    Eur J Surg Oncol; 1995 Oct; 21(5):548-50. PubMed ID: 7589604
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adjuvant fermented wheat germ extract (Avemar) nutraceutical improves survival of high-risk skin melanoma patients: a randomized, pilot, phase II clinical study with a 7-year follow-up.
    Demidov LV; Manziuk LV; Kharkevitch GY; Pirogova NA; Artamonova EV
    Cancer Biother Radiopharm; 2008 Aug; 23(4):477-82. PubMed ID: 18771352
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amelanotic malignant melanoma where primary lesion was discovered 5 years after metastasis in the lymph node.
    Kato H; Inoue Y; Ishihara T; Kageshita T; Ihn H
    J Dermatol; 2010 Aug; 37(8):730-4. PubMed ID: 20649717
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Specific active immunotherapy does not prolong survival in surgically treated patients with stage IIB malignant melanoma and may promote early recurrence.
    Hedley DW; McElwain TJ; Currie GA
    Br J Cancer; 1978 Apr; 37(4):491-6. PubMed ID: 646922
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metastatic malignant melanoma in pregnancy.
    Harkin KP; Drumm JE; O'Brien P; Daly A
    Ir Med J; 1990 Sep; 83(3):116-7. PubMed ID: 2228533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Therapy of malignant melanoma].
    Balch CM
    Dtsch Med Wochenschr; 1985 Nov; 110(46):1786-91. PubMed ID: 4054006
    [No Abstract]   [Full Text] [Related]  

  • 56. Systemic therapy of malignant melanoma.
    Seeger J; Richman SP; Allegra JC
    Med Clin North Am; 1986 Jan; 70(1):89-94. PubMed ID: 3510351
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tourniquet infusion with DTIC in therapy-resistant melanoma on the extremities: a pilot study.
    Jönsson PE; Ingvar C; Stridbeck H
    Recent Results Cancer Res; 1983; 86():213-7. PubMed ID: 6648001
    [No Abstract]   [Full Text] [Related]  

  • 58. A preliminary report of a pilot trial in adjuvant chemotherapy of primary melanoma.
    Kolarić K; Malenica B; Roth A
    Tumori; 1979 Apr; 65(2):229-36. PubMed ID: 462575
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adjuvant chemotherapy in the management of primary malignant melanoma.
    Banzet P; Jacquillat C; Civatte J; Puissant A; Maral J; Chastang C; Israel L; Belaich S; Jourdain JC; Weil M; Auclerc G
    Cancer; 1978 Apr; 41(4):1240-8. PubMed ID: 346192
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fatal hepatic vascular toxicity of DTIC. Is it really a rare event?
    Ceci G; Bella M; Melissari M; Gabrielli M; Bocchi P; Cocconi G
    Cancer; 1988 May; 61(10):1988-91. PubMed ID: 3359400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 259.